These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 17884968)
1. Decorin deficiency enhances progressive nephropathy in diabetic mice. Williams KJ; Qiu G; Usui HK; Dunn SR; McCue P; Bottinger E; Iozzo RV; Sharma K Am J Pathol; 2007 Nov; 171(5):1441-50. PubMed ID: 17884968 [TBL] [Abstract][Full Text] [Related]
2. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635 [TBL] [Abstract][Full Text] [Related]
3. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. Schaefer L; Raslik I; Grone HJ; Schonherr E; Macakova K; Ugorcakova J; Budny S; Schaefer RM; Kresse H FASEB J; 2001 Mar; 15(3):559-61. PubMed ID: 11259366 [TBL] [Abstract][Full Text] [Related]
4. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice. Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776 [TBL] [Abstract][Full Text] [Related]
5. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice. You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709 [TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy. Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771 [TBL] [Abstract][Full Text] [Related]
7. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy. Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969 [TBL] [Abstract][Full Text] [Related]
8. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483 [TBL] [Abstract][Full Text] [Related]
9. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777 [TBL] [Abstract][Full Text] [Related]
10. [Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells]. Dong FQ; Li H; Wu F; Yao HP Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3444-7. PubMed ID: 19159581 [TBL] [Abstract][Full Text] [Related]
11. Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. Merline R; Lazaroski S; Babelova A; Tsalastra-Greul W; Pfeilschifter J; Schluter KD; Gunther A; Iozzo RV; Schaefer RM; Schaefer L J Physiol Pharmacol; 2009 Oct; 60 Suppl 4(Suppl 4):5-13. PubMed ID: 20083846 [TBL] [Abstract][Full Text] [Related]
12. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy. Ninichuk V; Kulkarni O; Clauss S; Anders H- Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712 [TBL] [Abstract][Full Text] [Related]
13. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Usui HK; Shikata K; Sasaki M; Okada S; Matsuda M; Shikata Y; Ogawa D; Kido Y; Nagase R; Yozai K; Ohga S; Tone A; Wada J; Takeya M; Horiuchi S; Kodama T; Makino H Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380 [TBL] [Abstract][Full Text] [Related]
14. Role of fibrillin-1 in hypertensive and diabetic glomerular disease. Hartner A; Schaefer L; Porst M; Cordasic N; Gabriel A; Klanke B; Reinhardt DP; Hilgers KF Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1329-36. PubMed ID: 16380460 [TBL] [Abstract][Full Text] [Related]
15. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products. Lassila M; Seah KK; Allen TJ; Thallas V; Thomas MC; Candido R; Burns WC; Forbes JM; Calkin AC; Cooper ME; Jandeleit-Dahm KA J Am Soc Nephrol; 2004 Aug; 15(8):2125-38. PubMed ID: 15284298 [TBL] [Abstract][Full Text] [Related]
16. Critical role for osteopontin in diabetic nephropathy. Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530 [TBL] [Abstract][Full Text] [Related]